Evidence map›Paper›PMID 41094263›Full record

ReviewNature nanotechnology2025

Nanosensors for real-time intracellular analytics.

Einollah Sarikhani, Kuldeep Mahato, Ana Casanova, Keivan Rahmani, Joseph Wang, Zeinab Jahed

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Neuromorphic Devices and Computing for Sensing, Memory, and Control.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Bioelectronics forNanotheranostics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Einollah Sarikhani *Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA.
Kuldeep Mahato *Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA.
Ana CasanovaAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6341-1910
Keivan RahmaniAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA.
Joseph WangAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA. josephwang@ucsd.edu.ORCID http://orcid.org/0000-0002-4921-9674
Zeinab JahedAiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA. zjahed@ucsd.edu.ORCID http://orcid.org/0000-0002-0139-3219

Funding

United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (AF Office of Scientific Research) 311616-00001
6 · The paper itself

Abstract

A fundamental goal in modern biology and precision medicine is to acquire rich, multi-omics-style information from cells, including transcriptomic, proteomic, metabolic and electrophysiological data, in real time and at single-cell resolution. However, current techniques often rely on destructive endpoint assays that require cell lysis, losing spatial, temporal and dynamic context. Nanoscale sensors offer a transformative solution by enabling minimally invasive, continuous monitoring of intracellular activities. Here we propose a spatial classification of intracellular sensing technologies-near cell, on cell and in cell-and use this framework to evaluate the sensing modalities on the basis of their invasiveness, signal fidelity and resolution. We highlight emerging sensor platforms that are capable of detecting ions, metabolites, electrical signals and mechanical changes, as well as artificial intelligence-driven strategies for decoding complex cellular data streams. We further consider the integration of these nanosensors into three-dimensional, physiologically relevant models such as organoids to create 'smart organoids' that report on their internal state autonomously and in real time. Finally, we discuss the major challenges in achieving intelligent intracellular sensing, including issues of sensor miniaturization, biocompatibility, multiplexing and three-dimensional integration. Together, these advances set the stage for a new era of dynamic, high-resolution cell profiling that can accelerate drug discovery, disease modelling and personalized medicine.

Indexed as

Biosensing TechniquesNanotechnologyAnimalsHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.